Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Pluxee successfully places a €1.1 billion bonds issue
-
Music Licensing, Inc. Addresses Targeted False Narrative Campaign on Social Media
-
IIHS challenges automakers with tougher TOP SAFETY PICK award criteria
-
Bravo Property Trust Hires Gabi Moshayev
-
PALO ALTO NETWORKS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Palo Alto Networks, Inc. and Encourages Investors to Contact the Firm
-
LANTRONIX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Lantronix, Inc. and Encourages Investors to Contact the Firm
-
ILLUMINA ALERT: Bragar Eagel & Squire, P.C. is Investigating Illumina, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against B. Riley, Evolution, and NYCB and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioNTech, Mobileye, BioVie, and ADM and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against LuxUrban, and InMode and Encourages Investors to Contact the Firm
-
PANW INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Palo Alto Networks Inc. Investors with Substantial Losses Have Opportunity to Lead the Palo Alto Networks Class Action Lawsuit
-
Fortuna to release fourth quarter and full year 2023 financial results on March 6, 2024; Conference call at 12 p.m. Eastern time on March 7, 2024
-
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma
-
Sandfire Resources America Inc. Announces Win at the Montana Supreme Court with Complete Reinstatement of the Mine Operating Permit
-
Grupo Aeroportuario del Pacifico Announces Results for the Fourth Quarter of 2023
-
ASICS Study Confirms Positive Link Between Exercise and Women’s Mental Health, Yet Worryingly Over Half of Women Around the World Are Dropping Out or Stopping Exercise Completely
-
ROHM's EcoGaN™ Adopted in the 45W Output USB-C Charger C4 Duo from Innergie, a Brand of Delta
-
Bitterroot Bio and Biotheus Announce Research Collaboration to Develop Bispecific Proteins in Cardio-Immunology
-
ROHM's EcoGaN™ Adopted in the 45W Output USB-C Charger C4 Duo from Innergie, a Brand of Delta
-
The Future of Crypto Loans with $AITEK: Harnessing the Power of Smart Contracts to Offer a Better Loaning System
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages New York Community Bancorp, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NYCB
-
Zapp EV Reports Fiscal Year 2023 Financial Results
-
Ensurge Micropower ASA - Disclosure of Large Shareholdings
-
RTG Medical Ranks #70 on Inc. 5000 Regionals List in the Midwest
-
Black Rock Coffee Bar Unveils its Delicious Spring Drink Collection to Celebrate the Season
-
Urgently to Participate in Upcoming Investor Conferences
-
Douglas Dynamics Reports Fourth Quarter and Full Year 2023 Results
-
APA Corporation Announces Timeline For Closing of Callon Petroleum Company Transaction; Issues Investor Slide Deck Highlighting Top-Tier Permian Performance
-
Carlyle Secured Lending, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results, Increases Base Dividend to $0.40 Per Common Share and Declares First Quarter 2024 Dividends of $0.48 Per Co
-
Ibogaine Treatment May Be More Effective During the Month of March, According to David Dardashti
-
Volaris Reports Financial Results for the Fourth Quarter 2023: Net Income of USD $112 million
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Mobileye Global Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MBLY
-
Timbercreek Financial Announces 2023 Fourth Quarter Results and Special Dividend
-
Brookfield Corporation Announces Pricing of $750 Million Notes Offering
-
Greif, Inc. Declares Quarterly Dividend
-
Cricut to Present at Upcoming Investor Conferences
-
Agora, Inc. Reports Fourth Quarter and Fiscal Year 2023 Financial Results
-
Premier Health Reports 2024 First Quarter Results
-
Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement Agreement
-
BREAKING: Another city joins the call: Three weapons manufacturers across Canada are now blockaded in an effort to stop flow of weapons to Israel
-
Postal Realty Trust, Inc. Reports Fourth Quarter and Year End 2023 Results
-
iPower to Participate in the Water Tower Research Fireside Chat Series on February 28
-
Freddie Mac Issues Monthly Volume Summary for January 2024
-
Jasper Therapeutics to Present at the 43rd Annual TD Cowen Healthcare Conference
-
Eos Energy Enterprises Announces Dates for Fourth Quarter & Full Year 2023 Financial Results
-
Alta Equipment Group Appoints Sidhartha Nair as Director
-
Eightco announces early repayment of debt, private placement and certain changes at the parent company level
-
Travere Therapeutics to Present at Upcoming Investor Conferences
-
Eos Energy Enterprises Announces Dates for Fourth Quarter & Full Year 2023 Financial Results
-
Dorman Products, Inc. Reports Fourth Quarter and Full Year 2023 Results; Issues 2024 Guidance
